Abstract: Terlipressin, a synthetic analogue of vasopressin, has been employed
successfully against amine-resistant septic shock in both adults and children,
including an 8-day-old infant. There have been no previous reports of its
administration to premature infants. We report here on its compassionate use to
treat two premature neonates with hypotensive shock that resisted volume
replacement and amine therapy.